Literature DB >> 21075150

Calcium signaling in osteoclasts.

Sung-Yong Hwang1, James W Putney.   

Abstract

It has long been known that many bone diseases, including osteoporosis, involve abnormalities in osteoclastic bone resorption. As a result, there has been intense study of the mechanisms that regulate both the differentiation and bone resorbing function of osteoclast cells. Calcium (Ca(2+)) signaling appears to play a critical role in the differentiation and functions of osteoclasts. Cytoplasmic Ca(2+) oscillations occur during RANKL-mediated osteoclastogenesis. Ca(2+) oscillations provide a digital Ca(2+) signal that induces osteoclasts to up-regulate and autoamplify nuclear factor of activated T cells c1 (NFATc1), a Ca(2+)/calcineurin-dependent master regulator of osteoclastogenesis. Here we review previous studies on Ca(2+) signaling in osteoclasts as well as recent breakthroughs in understanding the basis of RANKL-induced Ca(2+) oscillations, and we discuss possible molecular players in this specialized Ca(2+) response that appears pivotal for normal bone function. This article is part of a Special Issue entitled: 11th European Symposium on Calcium. 2010. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21075150      PMCID: PMC3078988          DOI: 10.1016/j.bbamcr.2010.11.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  63 in total

1.  Decoding of cytoplasmic Ca(2+) oscillations through the spatial signature drives gene expression.

Authors:  Joseph Di Capite; Siaw Wei Ng; Anant B Parekh
Journal:  Curr Biol       Date:  2009-04-16       Impact factor: 10.834

Review 2.  Osteoimmunology and the effects of the immune system on bone.

Authors:  Hiroshi Takayanagi
Journal:  Nat Rev Rheumatol       Date:  2009-11-03       Impact factor: 20.543

3.  'Calcium-activated' intracellular calcium elevation: a novel mechanism of osteoclast regulation.

Authors:  M Zaidi; H K Datta; A Patchell; B Moonga; I MacIntyre
Journal:  Biochem Biophys Res Commun       Date:  1989-09-29       Impact factor: 3.575

4.  Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.

Authors:  Hiroshi Takayanagi; Sunhwa Kim; Takako Koga; Hiroshi Nishina; Masashi Isshiki; Hiroki Yoshida; Akio Saiura; Miho Isobe; Taeko Yokochi; Jun-ichiro Inoue; Erwin F Wagner; Tak W Mak; Tatsuhiko Kodama; Tadatsugu Taniguchi
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

5.  The role of calcium release activated calcium channels in osteoclast differentiation.

Authors:  Yandong Zhou; Tricia L Lewis; Lisa J Robinson; Kathy M Brundage; Rosana Schafer; Karen H Martin; Harry C Blair; Jonathan Soboloff; John B Barnett
Journal:  J Cell Physiol       Date:  2011-04       Impact factor: 6.384

6.  Control of cytosolic free calcium in rat and chicken osteoclasts. The role of extracellular calcium and calcitonin.

Authors:  A Malgaroli; J Meldolesi; A Z Zallone; A Teti
Journal:  J Biol Chem       Date:  1989-08-25       Impact factor: 5.157

Review 7.  Methods for studying store-operated calcium entry.

Authors:  Gary S Bird; Wayne I DeHaven; Jeremy T Smyth; James W Putney
Journal:  Methods       Date:  2008-10-16       Impact factor: 3.608

8.  RANKL-mediated reactive oxygen species pathway that induces long lasting Ca2+ oscillations essential for osteoclastogenesis.

Authors:  Min Seuk Kim; Yu-Mi Yang; Aran Son; Yu Shun Tian; Syng-Ill Lee; Sang Won Kang; Shmuel Muallem; Dong Min Shin
Journal:  J Biol Chem       Date:  2010-01-04       Impact factor: 5.157

9.  Calcium signal induced by mechanical perturbation of osteoclasts.

Authors:  S L Xia; J Ferrier
Journal:  J Cell Physiol       Date:  1995-06       Impact factor: 6.384

10.  The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor.

Authors:  J Davies; J Warwick; N Totty; R Philp; M Helfrich; M Horton
Journal:  J Cell Biol       Date:  1989-10       Impact factor: 10.539

View more
  40 in total

1.  NADPH oxidase 4 represents a potential target for the treatment of osteoporosis.

Authors:  Paula Hoff; Frank Buttgereit
Journal:  Cell Mol Immunol       Date:  2014-03-03       Impact factor: 11.530

Review 2.  The roles of Orai and Stim in bone health and disease.

Authors:  Lisa J Robinson; Harry C Blair; John B Barnett; Jonathan Soboloff
Journal:  Cell Calcium       Date:  2019-06-05       Impact factor: 6.817

3.  Integrative analysis of genome-wide association studies and gene expression profiles identified candidate genes for osteoporosis in Kashin-Beck disease patients.

Authors:  Y Wen; X Guo; J Hao; X Xiao; W Wang; C Wu; S Wang; T Yang; H Shen; X Chen; L Tan; Q Tian; H-W Deng; F Zhang
Journal:  Osteoporos Int       Date:  2015-10-13       Impact factor: 4.507

4.  Cell-surface phosphatidylserine regulates osteoclast precursor fusion.

Authors:  Santosh K Verma; Evgenia Leikina; Kamran Melikov; Claudia Gebert; Vardit Kram; Marian F Young; Berna Uygur; Leonid V Chernomordik
Journal:  J Biol Chem       Date:  2017-11-03       Impact factor: 5.157

5.  Resolvin E1 regulates osteoclast fusion via DC-STAMP and NFATc1.

Authors:  Min Zhu; Thomas E Van Dyke; Robert Gyurko
Journal:  FASEB J       Date:  2013-04-29       Impact factor: 5.191

6.  Orai1-mediated calcium entry plays a critical role in osteoclast differentiation and function by regulating activation of the transcription factor NFATc1.

Authors:  Sung-Yong Hwang; James W Putney
Journal:  FASEB J       Date:  2011-12-23       Impact factor: 5.191

7.  NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis.

Authors:  Claudia Goettsch; Andrea Babelova; Olivia Trummer; Reinhold G Erben; Martina Rauner; Stefan Rammelt; Norbert Weissmann; Valeska Weinberger; Sebastian Benkhoff; Marian Kampschulte; Barbara Obermayer-Pietsch; Lorenz C Hofbauer; Ralf P Brandes; Katrin Schröder
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

8.  Selective induction of P2Y14 receptor by RANKL promotes osteoclast formation.

Authors:  Seung Ah Lee; Jin Hee Park; Soo Young Lee
Journal:  Mol Cells       Date:  2013-09-17       Impact factor: 5.034

9.  Deletion of Orai1 alters expression of multiple genes during osteoclast and osteoblast maturation.

Authors:  Sung-Yong Hwang; Julie Foley; Takuro Numaga-Tomita; John G Petranka; Gary S Bird; James W Putney
Journal:  Cell Calcium       Date:  2012-10-31       Impact factor: 6.817

10.  Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.

Authors:  C Dou; Y Chen; N Ding; N Li; H Jiang; C Zhao; F Kang; Z Cao; H Quan; F Luo; J Xu; S Dong
Journal:  Osteoporos Int       Date:  2016-01-25       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.